Hepatitis B Diagnostic Tests Market is expected to grow at a 6.4% CAGR by 2028, attaining a valuation of US$ 1.26 Million

Despite the COVID-19 impact, the global Hepatitis B Diagnostic Tests Market grew at a solid year-on-year (YoY) rate, reaching a valuation of roughly US$ 872.5 Million in 2022. With the rising incidence of hepatitis B globally, the total market is expected to grow at a CAGR of 6.4% between 2022 and 2028, achieving a valuation of US$ 1.26 Million by the end of 2028.

Enzyme immunoassay (EIA) will continue to be the most favoured diagnostic test for hepatitis B detection, accounting for 89.9% of the market in 2022. Enzyme immunoassay kits provide several advantages, including shortened test time, a minimal sample size need, and rapid and reliable findings.

Request a Sample Report with Table of Content (ToC) @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1332

High Prevalence of Hepatitis B in the APEJ Region Boosting Global Market Revenue Growth

The prevalence of hepatitis B is highest in the APEJ region and the disease burden caused by chronic cases of hepatitis B is enormous. APEJ region has more number of chronic hepatitis B patients than any other region in the world and is thus a potential market for hepatitis B test kit manufacturers. As per the data provided by WHO, China accounts for one-third of all chronic hepatitis B infections. In addition, 6.2% of the adult population in the Western Pacific region is infected with hepatitis B.

In the South-East Asia region, an estimated 2% of the general population is infected with hepatitis B. According to Hepatitis Australia, approximately 225,000 people are living with chronic hepatitis B in the country. As per the data provided by WHO, in India, the prevalence of hepatitis B surface antigen is 3%-4.2% with over 40 million hepatitis B carriers. Due to such high prevalence of hepatitis B in the APEJ region, the market for hepatitis B diagnostic tests has a huge potential in the region.

Global Hepatitis B Diagnostic Tests Market: Segmentation and Forecast

The global hepatitis B diagnostic tests market is segmented on the basis of product type, end user and region.

• On the basis of product type, the enzyme immunoassay kits segment was estimated to be valued at nearly US$ 590 Mn in the year 2022 and is likely to reach a valuation of nearly US$ 1,100 Mn in 2028, accounting for a CAGR of 6.2% during the assessment period 2022-2028.

Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1332

• On the basis of end user, the hospitals segment was estimated to be valued at nearly US$ 250 Mn in 2022 and is estimated to reach a valuation of nearly US$ 460 Mn in 2028, registering a CAGR of 6.1% during the period of assessment.
• On the basis of region, the APEJ hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 200 Mn in 2022 and is likely to reach a valuation of nearly US$ 380 Mn in 2028, accounting for a CAGR of 7.2% during the period of forecast.

The HBV diagnostic assays typically involves several steps, including medical history, physical examination, blood tests, and imaging studies

Global Hepatitis B Diagnostic Tests Market: Competitive Landscape

• Bio-Rad Laboratories, Inc.
• DiaSorin S.p.A.
• Abbott Laboratories
• Meridian Bioscience
• bioMérieux SA Inc.
• Vista Diagnostics International
• Biogate Laboratories Ltd.
• J.Mitra & Co. Ltd.
• Siemens Medical Solutions USA, Inc.
• General Biologicals Corporation

Click here today to buy your full report @ https://www.futuremarketinsights.com/checkout/1332

Hepatitis B Diagnostic Tests Market By Category

Product Type:

• Enzyme Immunoassay Kits
  • Hepatitis B Surface Antigen Test
  • Anti-Hepatitis B Surface Antibody Test
  • Anti-Hepatitis B Core Antibody Test
• Point-of-Care Testing Kits
  • Strips
  • Cassettes/Cards

 End User:

• Hospitals
• Clinics
• Diagnostic Centres
• Home Care

About Future Market Insights (FMI) 

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs